502 related articles for article (PubMed ID: 21790291)
1. Novel insights on the role of the innate immune system in systemic sclerosis.
York MR
Expert Rev Clin Immunol; 2011 Jul; 7(4):481-9. PubMed ID: 21790291
[TBL] [Abstract][Full Text] [Related]
2. Early inflammatory players in cutanous fibrosis.
Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
[TBL] [Abstract][Full Text] [Related]
3. Immunological basis of systemic sclerosis.
Zuber JP; Spertini F
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii23-5. PubMed ID: 16987826
[TBL] [Abstract][Full Text] [Related]
4. New developments in the pathogenesis of systemic sclerosis.
Sakkas LI
Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
[TBL] [Abstract][Full Text] [Related]
5. Fibrosis and immune dysregulation in systemic sclerosis.
Chizzolini C; Brembilla NC; Montanari E; Truchetet ME
Autoimmun Rev; 2011 Mar; 10(5):276-81. PubMed ID: 20863906
[TBL] [Abstract][Full Text] [Related]
6. B cells in systemic sclerosis: a possible target for therapy.
Bosello S; De Luca G; Tolusso B; Lama G; Angelucci C; Sica G; Ferraccioli G
Autoimmun Rev; 2011 Aug; 10(10):624-30. PubMed ID: 21545850
[TBL] [Abstract][Full Text] [Related]
7. [Immunopathological disturbances in systemic sclerosis].
Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity in systemic sclerosis pathogenesis.
O'Reilly S
Clin Sci (Lond); 2014 Mar; 126(5):329-37. PubMed ID: 24219159
[TBL] [Abstract][Full Text] [Related]
9. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
Hasegawa M
J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
[TBL] [Abstract][Full Text] [Related]
10. Genetic background of systemic sclerosis: autoimmune genes take centre stage.
Allanore Y; Dieude P; Boileau C
Rheumatology (Oxford); 2010 Feb; 49(2):203-10. PubMed ID: 19923204
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the genetic background of systemic sclerosis.
Broen JC; Coenen MJ; Radstake TR
Expert Rev Clin Immunol; 2011 Jul; 7(4):449-62. PubMed ID: 21790288
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity and inflammation in systemic sclerosis.
Lafyatis R; York M
Curr Opin Rheumatol; 2009 Nov; 21(6):617-22. PubMed ID: 19633559
[TBL] [Abstract][Full Text] [Related]
13. NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Riemekasten G; Airo P; Melchers I; Hachulla E; Cerinic MM; Diot E; Hunzelmann N; Caramaschi P; Sibilia J; Tiev K; Mouthon L; Riccieri V; Cracowski JL; Carpentier PH; Distler J; Amoura Z; Tarner I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Ann Rheum Dis; 2011 Apr; 70(4):668-74. PubMed ID: 21149496
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis: an update.
Varga J
Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids.
Kontaki E; Boumpas DT
J Autoimmun; 2010 Nov; 35(3):206-11. PubMed ID: 20638241
[TBL] [Abstract][Full Text] [Related]
17. Systemic sclerosis.
Asano Y
J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
[TBL] [Abstract][Full Text] [Related]
18. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
[TBL] [Abstract][Full Text] [Related]
19. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
20. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
